Description

Researched for weight management and metabolic health.
A next-generation triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. Currently the subject of active clinical research, Retatrutide is studied for its role in metabolic regulation and energy homeostasis. Supplied as a lyophilized powder, 20mg per vial. Purity verified by Janoshik independent lab testing.